Logo image of ISEE

IVERIC bio Inc (ISEE) Stock Analyst Earnings Estimates

NASDAQ:ISEE - Nasdaq - US46583P1021 - Common Stock - Currency: USD

39.95  +0.15 (+0.38%)

After market: 39.94 -0.01 (-0.03%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
ISEE revenue by date.ISEE revenue by date.
51.5M
24.70%		50.9M
-1.17%		210M
312.57%
-100.00%		10.253M115.56M
1,027.08%		345.93M
199.35%		615.92M
78.05%		998.72M
62.15%		1.381B
38.28%		1.725B
24.91%		1.984B
15.01%
EBITDA
YoY % growth
ISEE ebitda by date.ISEE ebitda by date.
-122.8M
-52.74%		-194.8M
-58.63%		110.8M
156.88%		-60.18M
-158.75%		N/A
6.14%		-91.347M
-45.01%		-109.926M
-29.48%		-176.886M
-65.42%		-236.497M
-24.62%		-174.783M
26.09%		48.347M
127.66%		214.84M
344.37%		583.76M
171.72%		1.238B
112.07%		1.902B
53.63%		2.471B
29.92%
EBIT
YoY % growth
ISEE ebit by date.ISEE ebit by date.
-123.5M
-53.42%		-195.6M
-58.38%		108M
155.21%		-60.18M
-160.46%		-60.531M
6.13%		-80.435M
-44.70%		-112.935M
-29.38%		-176.574M
-65.49%		-247.949M
-30.56%		-184.704M
25.51%		-12.073M
93.46%		228.93M
1,996.29%		522.66M
128.31%		835.31M
59.82%		1.105B
32.29%		1.303B
17.92%
Operating Margin
ISEE operating margin by date.ISEE operating margin by date.
-239.81%-384.28%51.43%N/AN/AN/AN/AN/A-2,418.31%-159.83%-3.49%37.17%52.33%60.49%64.06%65.68%
EPS
YoY % growth
ISEE eps by date.ISEE eps by date.
-3.02
-2.03%		-5.45
-80.46%		3.17
158.17%		-1.59
-152.68%		-1.36
18.46%		-1.01
16.28%		-1.11
0.88%		-1.46
-34.51%		-1.84
-21.05%		-1.32
28.10%		-0.03
97.43%		1.32
3,980.29%		3.49
164.83%		4.27
22.19%		5.09
19.24%		5.72
12.42%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 23 Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.52
-25.63%		-0.50
-44.26%		-0.46
1.26%		-0.41
23.02%		-0.37
27.72%		-0.28
44.44%		-0.24
47.25%
Revenue
Q2Q % growth		3.233M8.702M10.29M20.15M33.052M
922.33%		48.253M
454.50%
EBITDA
Q2Q % growth		-76.817M
-54.54%		-75.803M
-78.65%		-71.267M
-13.42%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-69.803M
-40.30%		-69.446M
-63.36%		-66.144M
-5.04%		-48.246M
34.66%		-37.23M
46.66%		-21.93M
68.42%		-9.996M
84.89%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2023
Q2Q % growth		 -0.53
-82.76%		-0.48-0.05-11.29%
Q4 2022
Q2Q % growth		 -0.47
-62.07%		-0.38-0.09-22.88%
Q3 2022
Q2Q % growth		 -0.35
-52.17%		-0.410.0615.07%
Q2 2022
Q2Q % growth		 -0.41
-28.12%		-0.32-0.09-27.83%
Q1 2022
Q2Q % growth		 -0.29 -0.300.013.07%
Q4 2021
Q2Q % growth		 -0.29
-7.41%		-0.25-0.04-15.86%
Q3 2021
Q2Q % growth		 -0.23
14.81%		-0.290.0621.64%
Q2 2021
Q2Q % growth		 -0.32 -0.27-0.05-20.43%
Q1 2021
Q2Q % growth		 -0.29
-3.57%		-0.25-0.04-14.18%
Q4 2020
Q2Q % growth		 -0.27
30.77%		-0.26-0.01-3.40%
Q3 2020
Q2Q % growth		 -0.27 -0.22-0.05-21.15%
Q2 2020
Q2Q % growth		 -0.32 -0.320.00-1.20%
Q1 2020
Q2Q % growth		 -0.28
6.67%		-0.400.1229.61%
Q4 2019
Q2Q % growth		 -0.39 -0.29-0.10-36.55%
Q1 2019
Q2Q % growth		 -0.30 -0.370.0718.30%
ISEE Yearly EPS VS EstimatesISEE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 4 -4
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
ISEE Yearly Revenue VS EstimatesISEE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.77% -2.87% 0% -1.26%
RevenueN/A N/A 0% -15.23%